ARCHIVES

In Brief: House, Senate Pass Rescision Bills; NCI Compromise Figure Probably About $10 Million Cut For FY 1981

This article is from The Cancer Letter archive.

Vol. 07 No. 22 | May 29, 1981

Download PDF Visit The Full Archive

Related Articles

Lenalidomide Found Effective For Lymphoma In Phase II Trial

December 26, 2008

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

Gene Variant Associated With 44 Percent Cancer Risk Reduction

October 26, 2012

NCAB Can’t Decide Fate of Women’s Health Trial, Forces It Back Into Lap of DCPC Scientific Advisors

October 2, 1987

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005

AACI Asks Funding Of Cancer Control Directors From Control Budget

February 11, 1983